Organizational Decision-Making
Overview
A core leadership competency in biotech encompassing who decides, how decisions are communicated, and preventing post-meeting 'decision shopping'; John Cox and Ann Lee both advocate for single-decision-maker models with mandatory debate followed by fully unified execution. Fast and high-quality decision-making in biotech organizations stems from crisp decision ownership at the right organizational level — not from more committees or RACI diagrams — and requires actively crushing bureaucracy by minimizing layers between decision and action. Cox's approach mandates naming a decision owner for each decision, requiring full debate of all perspectives, then committing universally to the chosen path with no post-meeting lobbying — a protocol he establishes with every leadership team he joins. (Segment 3 (10:00-15:00))
Sign in to read the full article.
Sign In